Truist Securities analyst Bertrand Donnes initiated coverage on BKV Corporation (NYSE:BKV) with a Buy rating and a price ...

Truist analyst Bertrand Donnes initiated coverage of BKV Corp. (BKV) with a Buy rating and $24 price target The SMID-cap energy company has ...

KeyBanc Capital Markets initiated coverage of BKV Corp. (NYSE:BKV) with an "overweight" rating and set a price target of $23 ...

Analysts at KeyCorp issued their Q3 2024 earnings estimates for shares of BKV in a research note issued to investors on ...

Fintel reports that on October 25, 2024, Truist Securities initiated coverage of BKV (NYSE:BKV) with a Buy recommendation.

BKV Corporation (NYSE:BKV – Get Free Report) has been given an average recommendation of “Buy” by the eight analysts that are currently covering the firm, Marketbeat.com reports. Eight analysts have ...

KeyBanc initiated coverage of BKV Corp. (BKV) with an Overweight rating and $23 price target BKV is primarily a natural gas-focused ...

Obesity-drug developer BioAge Labs Inc. held on to a slim gain at the closing bell and natural-gas producer BKV Corp. ended flat Thursday, the day the two initial public offerings debuted.

I write articles about Thailand's financial markets and economy. Shares of BKV Corp—a unit of Thailand’s billionaire Vongkusolkit family-led Banpu—closed flat in its trading debut on ...

Sept 26 (Reuters) - Shares of BKV (BKV.N), opens new tab rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas producer a market capitalization of $1.56 ...

KeyBanc initiated coverage of BKV Corp. (BKV) with an Overweight rating and $23 price target BKV is primarily a natural gas-focused exploration and production company, the analyst tells investors ...

Investing.com -- KeyBanc Capital Markets initiated coverage of BKV Corp. (NYSE:BKV) with an "overweight" rating and set a price target of $23 per share. The analysts see BKV as a unique player in ...